- About Us
- For Patients
- Contact Us
Board of Directors
DAVID B. SPRINGER
David B. Springer, President and Chief Executive Officer, brings more than 20 years of experience in the healthcare and medical devices industries. Most recently, Springer held the position of President & Chief Executive Officer at CHF Solutions where among his many achievements was a successful acquisition of the company by Gambro. Prior to this, Springer held the position of Sr. Vice President for St. Jude Medical where he was successful in creating and leading all US strategic and operational plans. In 1997, he was a member of the founding management team of WebMD (formerly QDCS, Inc.) where he held the positions of Executive Vice President of Business Development and Senior Vice President of Sales. Prior to WebMD, Springer served in various leadership positions in sales, corporate accounts and marketing at Intermedics, Kimberly Clark Healthcare and Procter & Gamble. Springer received his Bachelor of Science in Industrial Management from Purdue University in West Lafayette, IN.
DAVID W. STASSEN
David W. Stassen is a founding Managing Director of Split Rock Partners and a member of the firms health care investment team. While his investing purview spans the country, Stassen focuses particularly on the strong medical technology industry in Minnesota. Prior to founding Split Rock Partners, Stassen was a General Partner with St. Paul Venture Capital’s health care team. He rejoined St. Paul Venture Capital in 2000, nine years after he left the firm to lead Spine-Tech, an emerging growth company specializing in development and marketing of revolutionary spinal implant products. Stassen led Spine-Tech from its formation in 1991 through growth in revenue to over $100 million. The company was acquired in January 1998 for over $600 million. Stassen began his business career with IBM Corporation. He holds a bachelors degree in quantitative methods and an MBA from the University of St. Thomas in St. Paul, MN.
MICHAEL C. SHERMAN
Michael C. Sherman has been a partner of MB Venture Partners since he joined the firm after a successful 15-year career at Memphis-based Medtronic Sofamor Danek (MSD), a subsidiary of Medtronic. Sherman joined Danek as the Director of Product Development in early 1991. In 1999, Sherman assumed the position of Vice President of Technology Development where he was responsible for technical and business due diligence on acquisitions, in-licensing activities, and strategic investments. Sherman is an inventor of MSDs SEXTANT System and has 66 issued US patents with over 30 pending applications. Sherman received his Bachelor of Science degree in Biomedical Engineering from Rensselaer Polytechnic Institute in Troy, NY, and a Master of Science degree in Biomedical Engineering from the University of Texas, Southwestern Graduate School in Dallas, TX.
Peter Kleinhenz has been a Venture Partner at Fletcher Spaght Ventures since 2009, and has been actively involved in technology-based businesses as an entrepreneur, consultant and investor for over 25 years. Previously he served as a consultant to The Cleveland Clinic Foundation, Battelle, and a variety of life science start-ups, assisting in developing business plans and raising seed and venture capital. He was CEO and owner of Progenics, a product development and pilot manufacturing company for medical products and industrial controls, which he sold in 1997. Peter was the second employee of Neoprobe, a biotech and medical device company focused on cancer, and served in a variety of senior executive positions including CFO, VP of Manufacturing, and VP of Strategic Planning and Business Development. Peter received an MBA from The Weatherhead School of Management at Case Western Reserve University and a bachelor’s degree in history from Loyola University of Chicago.
STEPHEN M. CAMPE
Stephen M. Campe joined Investor Growth Capital’s New York office in 1998 as Managing Director with a primary focus on medical device investments. He has been President of IGC and member of the Management Group of Investor AB since 2008 with responsibility for Investor Growth Capital’s activities in the US, Europe and Asia. Prior to joining IGC, Campe was a consultant at McKinsey & Co. where he worked on corporate finance and strategy engagements for several diversified health care and industrial companies. Prior to McKinsey, he was an investment banker specializing primarily in mergers and acquisitions for medical technology and diagnostics companies. Campe earned an M.B.A. from Yale School of Management and a B.S. in Economics and a B.A. in Systems Science Engineering from the University of Pennsylvania. He currently serves as a board member of several companies including Applied Spine, Galil Medical, CHF Solutions and Intuity Medical. Over the past 10 years, Campe has led numerous medical technology investments on behalf of IGC, including notable companies such as Intuitive Surgical (NASDAQ: ISRG) and Kyphon (acquired by Medtronic).
STEVEN L. GEX
Steven L. Gex, a founding member of the Cayenne Board of Directors, is presently the Chief Executive Officer of BioLucent and a former Chairman of the Board of Opus Medical. Before joining BioLucent, Gex held the positions of President and Chief Executive Officer of Biopsys Medical. Gex has also served as Vice President of Marketing at Laurus Medical Corp and Applied Medical Resources, both of which he co-founded. Additionally, Gex has held senior management positions in marketing, business development and manufacturing operations at Edwards Laboratories, a division of American Hospital Supply Corporation. Gex holds a Bachelor of Science degree in Marketing from San Diego State University in San Diego, CA.